“What conditions can stem cell therapy treat?” sounds like a simple question. It is not, because the word “treat” means three very different things depending on who is saying it.
In a hospital, stem cell therapy has treated certain blood disorders and cancers for decades, under strict regulation. In a regenerative medicine clinic, it is used for joints, spine and other problems, mostly as an investigational option. And in advertising, it is sometimes described as helping with nearly everything from arthritis to autism to aging.
This guide separates those worlds. It sorts conditions into clear evidence tiers, tells you what each tier really means, and gives you a checklist for evaluating any clinic in Miami, including ours.
What Can Stem Cell Therapy Actually Treat?
Established, FDA-approved stem cell treatments are limited to blood-forming cord blood products for disorders that affect blood production, plus one mesenchymal stem cell product approved in December 2024 for a specific pediatric transplant complication. Beyond that, stem cell injections are used in regenerative clinics for conditions such as knee osteoarthritis, with early or mixed research for spine, tendon, nerve, hair and some other problems. These uses are investigational, results vary, and many widely advertised claims (autism, Alzheimer’s, anti-aging, “autoimmune cures”) are not proven. A good rule: the more a clinic claims it can treat, the more carefully you should check the evidence.
The Four Tiers: A Simple Way to Sort Conditions
Use this framework for any stem cell claim you read.
| Tier | What it means | Examples |
|---|---|---|
| Tier 1: FDA-approved or established hospital use | Approved products or long-standing transplant medicine, delivered under regulation | Blood-forming cord blood products for blood-production disorders; stem cell transplants for certain blood cancers; one MSC product for pediatric steroid-refractory acute GVHD |
| Tier 2: Investigational with meaningful human research | Multiple human studies, mixed or modest results, not approved | Knee osteoarthritis, early avascular necrosis (with surgery), some disc and tendon conditions |
| Tier 3: Early or experimental | Small studies or mostly laboratory and animal data | Neuropathy, hair loss, some neurological and autoimmune conditions, erectile dysfunction |
| Tier 4: Unproven or not supported | Claims without reliable human evidence, or biologically implausible | “Cures” for autism, dementia, aging, most chronic diseases through a single injection or IV |
Keep this table handy. It will help you decide where a claim belongs, and how much weight to give it.
Tier 1: Established and FDA-Approved Uses
Blood-forming stem cells for blood disorders
The FDA states that the only stem cell products currently approved in the United States are blood-forming (hematopoietic) stem cells derived from umbilical cord blood, approved for patients with disorders that affect the production of blood, and that they are not approved for other uses. See the FDA’s page on important patient and consumer information about regenerative medicine therapies.
Related and long-standing is hematopoietic stem cell (bone marrow) transplantation, used in hospitals for certain blood cancers and blood and immune system diseases. The National Cancer Institute explains how these transplants work. This is a major medical procedure with intensive preparation and significant risks, and it is not the same thing as an outpatient injection in a regenerative clinic.
The first approved MSC therapy
In December 2024 the FDA approved remestemcel-L-rknd (Ryoncil) as the first mesenchymal stem cell therapy, for steroid-refractory acute graft-versus-host disease in children aged 2 months and older. According to the FDA announcement, approval was based on a single-arm study of 54 pediatric patients after allogeneic stem cell transplant, with a 70% overall response rate at day 28. Common side effects included infections, fever, bleeding, swelling, abdominal pain and high blood pressure.
Two lessons from this example:
- Approval is specific. Ryoncil is approved for one complication in one population. That does not mean MSCs are approved for knees, backs or aging.
- The approval process is rigorous. It required a defined product, a defined manufacturing process and clinical trial data. That is the standard other uses will have to meet.
Tier 2: Investigational Uses With Meaningful Human Research
This is where most outpatient regenerative medicine happens. “Investigational” means not FDA-approved for that use. It does not mean useless, but it does mean you should expect uncertainty.
Knee osteoarthritis
The most studied outpatient use. A 2025 meta-analysis of 6 randomized trials (300 patients) in the Journal of Orthopaedic Surgery and Research (abstract) found moderate-to-large WOMAC improvements at 12 months after a single MSC injection. A separate 2025 meta-analysis in Frontiers in Medicine (PDF) found that much of the improvement could be attributed to contextual (placebo-type) effects, with MSCs adding a modest extra benefit and the certainty of evidence rated low. Both can be true: a real but modest effect, with plenty of room for hype.
Early avascular necrosis (AVN)
For early-stage hip AVN, a 2025 meta-analysis in Frontiers in Pharmacology (full text) of 15 studies and 954 hips found that adding regenerative therapy to core decompression lowered the risk of collapse and of hip replacement compared with core decompression alone, though the studies varied and follow-up was short. Our detailed guide: stem cell therapy for avascular necrosis in Miami.
Disc and low back conditions
A 2021 meta-analysis in Stem Cells International (abstract) found lower pain and disability scores after MSC therapy for degenerative disc disease, but also more treatment-related adverse events in the stem cell group.
Rotator cuff and tendon problems
A 2024 review in IJMS (abstract) describes promising laboratory results and an “excellent safety profile” for cell-based therapy in the rotator cuff, but mixed randomized results in people. See rotator cuff stem cell therapy and regenerative medicine for Achilles tendon injury.
For a deeper tour of these orthopedic and related uses, read our companion guide, 9 ailments stem cell therapy can treat.
Tier 3: Early or Experimental Uses
Here the research is smaller, earlier or mostly preclinical. Some of these uses may eventually become mainstream; others may not.
Peripheral and diabetic neuropathy
A 2024 meta-analysis in Stem Cell Research & Therapy (abstract) pooled 7 controlled human trials and reported improvements in nerve conduction velocity and symptom scores, with injection-site pain and swelling as the main side effects. The authors called for more research. Learn more: does stem cell therapy work for neuropathy and stem cell therapy for diabetic neuropathy.
Hair loss
A 2023 systematic review in Cells of 15 studies (653 participants) found promising increases in hair density in several studies, but the studies were too varied to pool and only some had control groups. See our guide to stem cell therapy for hair loss in Miami.
Carpal tunnel, foot, ankle and hand conditions
Research here is limited, and clinics often extrapolate from other joints. See stem cell therapy for carpal tunnel syndrome, foot and ankle pain and hand and finger arthritis.
Neck pain and sports injuries
Evidence is limited and often borrowed from similar conditions. See stem cell therapy for neck pain in Miami and regenerative medicine for sports injuries.
Autoimmune conditions
Researchers are studying stem cell approaches for some autoimmune diseases, and in certain severe cases hospital-based transplant procedures are being investigated in trials. But outpatient IV products marketed for “autoimmune” conditions are not proven. Our pages on stem cell therapy for autoimmune diseases and IV stem cell therapy for autoimmune conditions discuss this carefully. If you have an autoimmune condition, involve your specialist before considering any regenerative treatment.
Lung disease
Laboratory and early clinical research exists, but there is no established outpatient stem cell treatment for COPD or other lung diseases. Read can stem cells help regenerate lungs and stem cell therapy for COPD and lung disease.
Erectile dysfunction
Interest is high and early studies exist, but the evidence is limited. See does stem cell therapy really work for ED and non-surgical ED treatment options.
Fibromyalgia
Research is early, and fibromyalgia involves complex pain processing that no single injection is likely to fix. See regenerative medicine for fibromyalgia.
Tier 4: Claims You Should Treat With Serious Caution
Some conditions come up often in advertising but are not established stem cell treatments.
Autism
No stem cell product is approved to treat autism, and the FDA lists it among conditions for which these products are not approved. Families are often vulnerable to bold claims here. If you are exploring options for a child, speak with your pediatrician and developmental specialists first, and read our careful discussion, can stem cell therapy help autism symptoms.
Alzheimer’s disease and dementia
Active research exists, but no stem cell treatment has been proven to stop or reverse dementia. See stem cell research for Alzheimer’s.
Anti-aging and “longevity”
There is no human trial showing that stem cell products or infusions slow or reverse aging. Our pages on anti-aging IV therapy and longevity and wellness IV drips describe how these are marketed, and it is worth reading them with the evidence tiers above in mind.
Cancer “cures”
Stem cell transplants are an established hospital treatment for some blood cancers. An outpatient stem cell injection is not a cancer cure, and no regenerative clinic product is approved to treat cancer. Be very cautious about any promise of that kind.
Stroke, spinal cord injury, ALS and other neurological conditions
Clinical trials are under way for several of these, and some early results are encouraging, but outpatient clinic products are not approved. For one example of how early the data are, see our review of Muse cell research and registries or our overview of mesenchymal stem cell clinical trials. If a legitimate trial exists for your condition, that is usually a safer route than a clinic offering the same thing for a fee.
What the FDA Says Patients Should Know
The FDA’s consumer information says plainly that the only approved stem cell products are the blood-forming cord blood products, that they are not approved for other uses, and that if you are offered unapproved products outside a clinical trial, you may be “deceived and offered a product illegally.” The FDA also warns of reported harms from unapproved products, including blindness, tumor formation and life-threatening blood infections. See also the FDA’s consumer update on stem cell therapies.
That is a strong statement, and it is worth taking seriously. At the same time, the regulatory picture is nuanced:
- Some procedures that use your own tissue in the same visit may be regulated differently from manufactured products.
- State laws add another layer. Our explainers on the state’s orthopedic MSC approval and the new stem cell law explain what changed and what did not.
- Legal availability does not equal proof of effectiveness.
The practical takeaway: ask every clinic which product it uses, where it comes from, and under what rules it is offered, and do not accept “FDA-approved” as an answer unless they can show you the approval for that exact use.
How Stem Cell Therapy Is Supposed to Work
Understanding the mechanism helps explain why some conditions respond better than others. Mesenchymal and other stem and progenitor cells are thought to work mainly through signaling: releasing proteins and other molecules that reduce inflammation, support blood vessel growth and encourage the body’s own repair cells. In most outpatient uses, the idea is not that injected cells become new knee cartilage or new nerve, but that they change the local environment so healing can proceed.
That explains a lot:
- It suits conditions where some living tissue remains to be supported.
- It is less suited to fully destroyed tissue.
- It depends on delivery to the right place, which is why a knee injection and an IV behave very differently.
For deeper explanations, see how stem cell therapy works and how stem cells enhance blood vessel formation.
How to Judge Evidence Like a Skeptic
You do not need a medical degree to tell a strong claim from a weak one. Five checks cover most situations.
1. What type of study is it? A randomized, placebo-controlled trial is stronger than an open-label study, which is stronger than a case series, which is stronger than a testimonial. A review or meta-analysis can be only as good as the studies it pools.
2. How many people were studied? Trials with a few dozen patients can hint at a signal, but they cannot prove a treatment works or detect rare side effects.
3. Was there a control group? Without one, improvement may come from natural recovery, rehabilitation or the placebo effect. Pain conditions, in particular, have a large placebo response, which is why the two knee meta-analyses above reached somewhat different conclusions.
4. What did the study measure? A change in an MRI or a lab value is not the same as feeling or functioning better. Look for outcomes that matter to you: pain, mobility, independence.
5. How long were patients followed? A result at 6 weeks says little about 2 years.
When a clinic says “studies show,” ask: which study, how many patients, what condition, what product, what was the main outcome, and how long was follow-up? A clinician who knows the research can answer in a sentence or two.
Why Some Conditions Respond Better Than Others
Several factors explain why the evidence is stronger for some conditions than others.
- Remaining healthy tissue. Cells that act through signaling need living tissue to support. Early or moderate joint wear fits this better than end-stage disease.
- Local delivery. A direct injection into a knee, shoulder or disc places the product where it is needed. An IV disperses it throughout the body, with much less certainty about what reaches the target.
- Blood supply. Tissues with poor blood supply, such as cartilage and tendon, heal slowly, which makes research results harder to achieve.
- Measurable outcomes. Joint pain and function are easier to measure than, for example, “overall wellness.”
- Research investment. Orthopedic uses have been studied more, simply because they are more common.
This is also why you should be wary of any single product claimed to help conditions as different as a torn tendon, diabetes complications, dementia and aging.
What Realistic Results Look Like
For conditions where stem cell therapy is used, a realistic outcome is usually partial improvement, not a cure.
| Result | What it looks like | Typical timing |
|---|---|---|
| Meaningful improvement | Less pain, better function, more activity | Gradual over 1 to 6 months |
| Modest improvement | Some relief but ongoing symptoms | Variable |
| No change | Same symptoms | Judged at the planned follow-up |
| Worsening or complication | Rare; needs medical review | Any time |
Responsible clinics explain these possibilities before treatment, define a follow-up point, and discuss next steps if there is no benefit. For realistic timing, see how soon you may notice improvement and how long results can last for joint regeneration.
Three Illustrative Scenarios
These are examples of how decisions can differ, not predictions or real patient stories.
Scenario 1: Moderate knee arthritis. A 58-year-old in Miami has moderate knee osteoarthritis, has tried physical therapy and injections, and wants to postpone a knee replacement. This is the profile for which the most research exists. A consultation would include imaging, a discussion of the mixed evidence, realistic expectations and a plan to measure results.
Scenario 2: A parent exploring autism options. A parent hears about stem cell treatment for a child with autism. This falls in Tier 4: no approved treatment and no reliable proof. The best next step is guidance from the child’s pediatrician and developmental team, evidence-based therapies and, if interested, a legitimate clinical trial rather than a paid clinic treatment.
Scenario 3: A person wanting “anti-aging.” An adult in good health wants an IV for longevity. There is no human evidence that it slows aging. A responsible provider would say so, and might suggest a check-up, sleep, exercise and nutrition review, which have real evidence behind them.
Clinical Trials: A Safer Route for Some Conditions
For conditions in Tiers 3 and 4, a legitimate clinical trial is often the better path than paying a clinic for an unproven product. Trials have oversight, informed consent, defined products and monitoring.
How to look for one:
- Search ClinicalTrials.gov for your condition plus “stem cell,” “mesenchymal” or “cell therapy.”
- Check the status (recruiting), phase, sponsor and location.
- Read the eligibility criteria carefully.
- Beware of “trials” where participants pay large fees, which the FDA has flagged as a warning sign.
- Discuss any trial with your own physician before enrolling.
Our overview of mesenchymal stem cell clinical trials explains the stages of research and why they take so long.
Practical Tips for Miami Patients
- Start with a diagnosis, not a product. Imaging and an exam come first.
- Ask where your condition falls on the four-tier scale above.
- Bring records, including MRI reports, medications and prior treatments.
- Get a second opinion from an orthopedist, neurologist or other specialist who knows your condition.
- Beware of urgency. Limited-time discounts are marketing, not medicine.
- Plan follow-up, especially if you are traveling to Miami for care.
- Keep your own records of the product, date, dose and provider.
If joint pain is your main concern, see our overview of stem cell therapy for joint pain in Miami and best non-surgical knee pain options.
Who Is a Good Candidate?
Across conditions, patients who tend to be better candidates:
- Have a clear diagnosis confirmed by imaging and an exam.
- Have an early to moderate stage of disease, with tissue left to support.
- Have tried or considered proven first-line care such as physical therapy or medication.
- Understand the treatment is investigational and results vary.
- Are in good general health without conditions that make the procedure unsafe.
Patients who tend to be poorer candidates include those with advanced, end-stage damage, active infection, certain cancers or bleeding disorders, or expectations of a guaranteed cure. Our guide on stem cell therapy vs. hip replacement shows how candidacy decisions play out in one common situation.
What a Typical Treatment Looks Like
Details vary by condition and clinic, but most outpatient regenerative visits include:
- Consultation and imaging review, including an honest discussion of whether you are a candidate.
- Cell collection if using your own cells (for example, a bone marrow draw or fat harvest under local anesthesia).
- Processing to concentrate the cells.
- Image-guided delivery to the target area.
- Aftercare and follow-up with activity guidance and a plan to measure results.
Read how stem cell therapy is done and the recovery timeline for more detail, and how many sessions you may need.
Risks and Side Effects
Possible issues include soreness, bruising and swelling, a temporary flare of pain, infection, bleeding, allergic or immune reactions (especially with donor-derived products), procedure-specific risks (the spine requires particular skill), and the real possibility of no benefit. The risks of unapproved products reported by the FDA are a reminder that product quality and sterility matter.
Cost and Insurance in Miami
Because most uses are investigational, insurance usually does not cover them, and patients should expect to pay out of pocket. Costs depend on the condition, the product, the number of treatments and follow-up. Request a written, itemized quote.
Stem Cells, PRP and Exosomes: Which Is Used for What?
Many people searching for the conditions stem cell therapy can treat are really comparing several regenerative options. They are different tools with different evidence.
| Option | What it is | Where it is most often used | Evidence picture |
|---|---|---|---|
| Stem cell or bone marrow concentrate | Cells and growth factors, usually from your own bone marrow or fat | Knee and hip arthritis, AVN, some spine and tendon problems | Moderate for knee osteoarthritis and early AVN; mixed or early elsewhere |
| PRP (platelet-rich plasma) | Concentrated platelets from your blood | Tendon problems, knee osteoarthritis, hair thinning | Larger evidence base for some uses; see our PRP therapy guide and PRP vs. stem cells for joint pain |
| Exosomes | Cell-derived vesicles, not living cells | Skin, hair, and “wellness” uses | Early; no FDA-approved product; see is exosome therapy FDA-approved |
| Muse cells | A rare cell subset under study | Research settings | Small early trials; see our Muse cell guide |
If a clinic offers one product for every condition on the list, treat that as a warning sign. The right tool depends on the tissue, the stage and the evidence for that combination. A thoughtful provider will often recommend the simplest, best-supported option first, which for many people is not a stem cell injection at all.
Questions to Ask Any Clinic
Bring this list to every consultation.
- What is my diagnosis and stage, and how do you know?
- Where does my condition fall on the evidence scale? Approved, investigational, early or unproven?
- What exactly will be injected, and where does it come from?
- What is the regulatory status of the product and the procedure?
- What studies support this for my condition, and what are their limits?
- What outcome should I expect, and when will we judge it?
- What are the risks, and how do you handle complications?
- What are the alternatives, including surgery or medication?
- What is the total cost, including follow-up?
- Who is the supervising physician?
Our guide to how to choose a stem cell therapy treatment center goes deeper on evaluating providers.
Red Flags: How to Spot an Overreaching Claim
- A list of dozens of unrelated conditions treated with one product.
- “Cure,” “reverse” or “guaranteed” language.
- Testimonials or before-and-after photos used as proof.
- No imaging or evaluation before a price is quoted.
- Pressure to prepay for a large package.
- Vague answers about the cell source or regulatory status.
- Telling you to stop other medical treatment.
- No mention of risks or limits.
A trustworthy clinic is comfortable saying “this is not for you” or “the evidence here is weak.”
Frequently Asked Questions
What conditions can stem cell therapy treat?
Established uses include blood-forming cord blood products for disorders affecting blood production, hospital stem cell transplants for certain blood cancers and diseases, and one approved MSC product for pediatric steroid-refractory acute GVHD. Outpatient regenerative uses such as knee osteoarthritis are investigational.
What is stem cell therapy most commonly used for in clinics?
Orthopedic conditions, especially knee osteoarthritis, along with some hip, shoulder, spine and tendon problems.
Is stem cell therapy FDA-approved for arthritis?
No. No stem cell product is FDA-approved for arthritis or other orthopedic conditions.
Can stem cell therapy cure anything?
No outpatient injection has been proven to cure a chronic disease. Hospital stem cell transplants can be curative for some blood conditions but are a very different medical procedure.
Does stem cell therapy work for autism?
There is no FDA-approved stem cell treatment for autism, and reliable evidence of benefit is lacking.
Does it work for Alzheimer’s or Parkinson’s?
Research is active, but no stem cell treatment is proven or approved for these conditions.
Does it work for back pain?
Some studies show reduced pain and disability for degenerative disc disease, with mixed safety signals. It is not guaranteed.
Can it treat neuropathy or hair loss?
Small studies suggest possible benefit for diabetic neuropathy and early hair thinning, but the evidence is early.
Is it covered by insurance?
Usually not, because it is considered investigational. Check with your insurer.
How do I know if I am a candidate?
Start with a diagnosis and imaging, then talk with a provider who will tell you honestly whether the evidence supports treatment in your case.
Is stem cell therapy safe?
Short-term side effects are usually mild, but infection, reactions and no benefit are possible, and long-term data are limited.
Should I join a clinical trial instead?
If a legitimate trial exists for your condition, it can be a safer, regulated route. Search ClinicalTrials.gov and ask your physician.
Bottom Line
So, what conditions can stem cell therapy treat? The honest answer has layers. Hospitals use stem cells to treat certain blood disorders and cancers. The FDA has approved one MSC product for a specific pediatric complication. Beyond that, regenerative clinics use stem cell injections mainly for orthopedic problems like knee osteoarthritis, with early or mixed evidence elsewhere, and none of those uses is FDA-approved. Be skeptical of any clinic that claims to treat everything.
If you are in Miami and want a straightforward opinion on where your condition falls and what your options are, you can book a free 15-minute consultation at Miami Stem Cell in South Miami or contact our team with your questions. You can also learn more about us and see our overview of regenerative medicine in Miami before you decide.
Disclaimer: Individual results vary. This is general information, not medical advice.
